INNOVATION | MEDICAL
Drug Master Files (DMF) at the FDA, including specific medical colour formulations. The company has also expanded its portfolio of
ABS grades for filament 3D printing to include a medical ABS and food contact grade for filament 3D printing that meets biocompatibility standards ISO 10993-1 and USP class VI for use in medical devices.
Advances in the field of microfluidics are consid-
ered one of the main breakthroughs in recent years in the medical devices sector, leading to several applications that hold promise for better under- standing the human body and tackling diseases. Microfluidics is the science underlying lab-on-
chip (LOC) technology, which allows for high- speed diagnostic testing. LOCs have been widely used in laboratories working on treatments for the SARS-CoV-2 virus and other infectious diseases, and they have also been employed in numerous other areas, including cancer research, editing genes and mapping the molecular state of diverse cell types in the human body. Demands in the market for microfluidic devices have always posed challenges along the supply chain, in processing, mould manufacturing, and
material performance. Constant innovation in each area has allowed for more precise and advanced applications to be developed. According to Polyplastics – which produces cyclic olefin copolymer (COC), branded Topas, a favoured polymer for microfluidic devices – events in 2020 boosted the market for microfluidic devices. Topas COC materials are very well suited to microfluidic devices, thanks to their mechanical, optical, and chemical properties as well as their
Above: Polyplastics says Topas COC is an ideal polymer for production of increasingly important microfluidic devices
Follow us on...
Be the first to know when we publish a new edition, plus updates on our conferences and useful links.
www.twitter.com/plasticsworld
IMAGE: POLYPLASTICS
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62
